April 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJune 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJuly 24, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 21, 2026
According to forecasts, the global healthcare facility management market will grow from USD 319.38 billion in 2024 to USD 870.75 billion by 2034, with an expected CAGR of 10.55%. With a growing number of patients, there is a growing demand for better care, patient safety, data security, and overall comfort of patients and their families. To do so, ...
April 21, 2026
Based on market forecasts, the corporate wellness sector will expand from USD 64.31 billion in 2024 to USD 130.03 billion by 2034, experiencing a CAGR of 7.35%. With growing awareness about health and well-being, organizations are focusing on developing programs that not only focus on one aspect of health but incorporate all aspects of health. The ...
April 21, 2026
Based on market forecasts, the clinical trial supply and logistics sector will expand from USD 4.03 billion in 2024 to USD 8.58 billion by 2034, experiencing a CAGR of 7.63%. The growing research and development activities like novel drugs, novel biologics, cell and gene therapy products, and combination therapies drive the market growth. Therefore...
April 21, 2026
Based on market forecasts, the population health management sector will expand from USD 85.59 billion in 2024 to USD 663.75 billion by 2034, experiencing a CAGR of 22.05%. The Population Health Management (PHM) market focuses on improving clinical outcomes through better care coordination, patient engagement, and data-driven decision-making....
April 21, 2026
Based on market forecasts, the global clinical trial investigative site network market, projected at USD 8.87 billion in 2024, is expected to reach USD 15.99 billion by 2034, growing at a CAGR of 6.07% over the forecast period. The rising number of clinical trials, growing pharmaceutical & biotechnology research, and technological advancements ...
April 21, 2026
Based on market forecasts, the global pharmaceutical logistic market, projected at USD 111.45 million in 2024, is expected to reach USD 191.1 million by 2034, growing at a CAGR of 5.54% over the forecast period. The demand for efficient and timely delivery of pharmaceuticals, growing research & development on novel drug development and biologic...
April 21, 2026
Market insights predict the global decentralized clinical trials (DCTs) industry will increase from USD 9.53 billion in 2024 to USD 38.2 billion by 2034, achieving a CAGR of 14.9%. The demand for DCTs is increasing because they do not require patients or volunteers to conduct the research. This becomes more important considering the fact that many ...
April 21, 2026
According to projections, the global microbial testing service market was estimated at US$ 6.39 billion in 2025 and is projected to grow to US$ 9.89 billion by 2030. The microbial testing service market is expanding due to rising infectious diseases and regulatory standards ensuring patient safety. The pharmaceutical industry's growth fuels demand ...
April 21, 2026
According to market projections, the global physician practice management market, valued at USD 129 billion in 2024, is anticipated to reach USD 291.7 billion by 2034, growing at a CAGR of 8.5% over the next decade. The increasing number of hospitalizations, technological advancements, rapidly expanding healthcare infrastructure, and favorable gove...
April 21, 2026
According to market projections, the pharmaceutical CDMO sector is expected to grow from USD 167.96 billion in 2025 to USD 337.89 billion by 2035, reflecting a CAGR of 7.24%. Pharma companies face challenges in researching and manufacturing new therapies. Partnering with a CDMO helps by offering expertise, scalability, and cost savings....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
